ID26341A - Proses untuk penyediaan dosis yang tetap stabil komposisi zat-zat zat anti infeksi dan mikroorganisme sebagai bahan obat-obatan aktif - Google Patents

Proses untuk penyediaan dosis yang tetap stabil komposisi zat-zat zat anti infeksi dan mikroorganisme sebagai bahan obat-obatan aktif

Info

Publication number
ID26341A
ID26341A IDW991648A ID991648A ID26341A ID 26341 A ID26341 A ID 26341A ID W991648 A IDW991648 A ID W991648A ID 991648 A ID991648 A ID 991648A ID 26341 A ID26341 A ID 26341A
Authority
ID
Indonesia
Prior art keywords
infection
active drug
stable composition
drug materials
providing dosage
Prior art date
Application number
IDW991648A
Other languages
English (en)
Inventor
Bansal Yatish Kumar
Khamar Bakulesh Mafalal
Modi Rajiv Indravadam
Original Assignee
Cadila Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9806489.2A external-priority patent/GB9806489D0/en
Application filed by Cadila Pharm Ltd filed Critical Cadila Pharm Ltd
Publication of ID26341A publication Critical patent/ID26341A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IDW991648A 1998-03-27 1998-04-03 Proses untuk penyediaan dosis yang tetap stabil komposisi zat-zat zat anti infeksi dan mikroorganisme sebagai bahan obat-obatan aktif ID26341A (id)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9806489.2A GB9806489D0 (en) 1998-03-27 1998-03-27 The process for the preparation of a stable fixed dose pharmaceutical composition of anti-infective agent/agents and micro organisms as active ingredients
LK1644598 1998-03-27
PCT/IB1998/000445 WO1999049875A1 (en) 1998-03-27 1998-04-03 The process for the preparation of a stable fixed dose pharmaceutical composition of anti infective agent/agents and micro organisms as active ingredients

Publications (1)

Publication Number Publication Date
ID26341A true ID26341A (id) 2000-12-14

Family

ID=26313367

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW991648A ID26341A (id) 1998-03-27 1998-04-03 Proses untuk penyediaan dosis yang tetap stabil komposisi zat-zat zat anti infeksi dan mikroorganisme sebagai bahan obat-obatan aktif

Country Status (9)

Country Link
EP (1) EP0998295A1 (id)
JP (1) JP2002516616A (id)
AP (1) AP9901724A0 (id)
AU (1) AU770024B2 (id)
CA (1) CA2291780A1 (id)
EA (1) EA002148B1 (id)
ID (1) ID26341A (id)
UA (1) UA59394C2 (id)
WO (1) WO1999049875A1 (id)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8227235B2 (en) * 2008-12-10 2012-07-24 Alpharma, Llc Compositions and methods for controlling diseases in animals
GB0916335D0 (en) * 2009-09-17 2009-10-28 Martin W J Medicaments
WO2011086575A2 (en) * 2010-01-13 2011-07-21 Toyochem Laboratories A pharmaceutical composition for treatment of respiratory tract infections
US11554112B2 (en) 2018-06-07 2023-01-17 Herum Therapeutics International Limited Combinations of β-lactam compounds and probenecid and uses thereof
EA202192193A1 (ru) * 2019-02-13 2021-11-09 Итерум Терапьютикс Интернэшнл Лимитед Комбинации бета-лактамных соединений и пробенецида и их применения

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8703360L (sv) * 1987-08-31 1989-03-01 Lejus Medical Ab Granulaera produkter (iii)

Also Published As

Publication number Publication date
WO1999049875A1 (en) 1999-10-07
AP9901724A0 (en) 1999-12-31
EA002148B1 (ru) 2001-12-24
EA199900938A1 (ru) 2000-08-28
EP0998295A1 (en) 2000-05-10
AU770024B2 (en) 2004-02-12
AU6415698A (en) 1999-10-18
CA2291780A1 (en) 1999-10-07
JP2002516616A (ja) 2002-06-04
UA59394C2 (uk) 2003-09-15

Similar Documents

Publication Publication Date Title
EE04238B1 (et) Asendatud 1,2,3,4-tetrahüdronaftaleeni derivaadid, meetod selle valmistamiseks, nimetatud terapeutilise toimega aineid sisaldavad ravimkoostised ja nimetatud aktiivsete ühendite kasutamine teraapias
US4732892A (en) L-α-amino acids as transdermal penetration enhancers
DE69931930D1 (de) Verbindungen und zusammensetzungen zur verabreichung aktiven substanzen
DE69531741D1 (de) Verbindungen und zusammensetzungen zur verabreichung aktiver stoffe
IT1283102B1 (it) Composizione terapeutica per la somministrazione transdermica di un principio attivo estrogeno o progestinico o di loro miscele
HUP9801331A3 (en) Tricyclic amide and urea derivatives useful for inhibition of g-protein function and for treatment of proliferative diseases, novel tricyclic amide and urea derivatives, use thereof, pharmaceutical compositions containing these compounds as active ...
ES2145913T3 (es) Inhibidores de metaloproteasas.
MA26563A1 (fr) Composes therapeutiquement actifs contenant de l'indazole en remplacement bio-isosterique du catechol, leur preparation et composition pharmaceutique les contenant
SE9700135D0 (sv) New formulation
DE69430132D1 (de) Pernasale zusammensetzung und diese enthaltende pernasale zubereitung
ES2060593T3 (es) Sistema de aporte de farmacos.
EE04399B1 (et) Spiroasabitsüklilised heterotsüklilised ühendid, nende valmistamise protsess, neid sisaldavad ravimkoostised ja nende kasutamine ravis
MA23632A1 (fr) Procede de preparation de composes nouveaux et de compostions pharmaceutiques les contenant
DE69433818D1 (de) Kombinierte wirkstoffe als methode zur gezielten wirkstoff-freisetzung
ATE224717T1 (de) Oral anzuwendende arzneizubereitungen enthaltend eine benzhydrylpiperazine und eine zyklodextrin
DK1069892T3 (da) Fugtighedsaktiverbart terapeutisk system
ATE220547T1 (de) Arzneimittelformulierung mit kontrollierter wirkstofffreisetzung
FI951053A (fi) Nanohiukkasia, jotka sisältävät vaikuttavaa ainetta ja polyketaaliviinihappoamidia, menetelmä niiden valmistamiseksi ja niiden käyttö
ID26341A (id) Proses untuk penyediaan dosis yang tetap stabil komposisi zat-zat zat anti infeksi dan mikroorganisme sebagai bahan obat-obatan aktif
SE9704400D0 (sv) Porous inorganic particles as carriers for drug substances
EP0418341A4 (en) Percutaneous drug delivery system
HUP0401013A3 (en) Active substance combination for medicamentous therapy of nicotine dependency and pharmaceutical composition containing it
IT1301969B1 (it) Sucralfato gel secco granulare e poroso procedimento per la suapreparazione, e composizioni farmaceutiche solide che lo contengono
NO983098L (no) Hudheftende farmas°ytisk preparat, spesielt transdermalt terapeutisk system for frigivelse av 17-<beta>-estradiol til den menneskelige organisme
AR002735A1 (es) Formulaciones liquidas de sustancias insecticidas activas.